Clinical Trial Update: Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone Caproate [NA]

View source ↗

Summary

A clinical trial evaluating 17 Alpha-hydroxyprogesterone caproate for treatment of preterm labor has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Birth
• Premature Labor

Drugs mentioned

• 17-alpha-hydroxyprogesterone caproate (17-alpha-hydroxyprogesterone caproate)

Snippet

Sponsor: Yale University | Conditions: Premature Birth, Premature Labor | NA | Status: WITHDRAWN